Literature DB >> 22648798

α-Catulin marks the invasion front of squamous cell carcinoma and is important for tumor cell metastasis.

Christine Cao1, Yibu Chen, Rizwan Masood, Uttam K Sinha, Agnieszka Kobielak.   

Abstract

Squamous cell carcinomas (SCC) comprise the most common types of human epithelial cancers. One subtype, head and neck squamous cell carcinoma (HNSCC), is a particularly aggressive cancer with poor prognosis due to late diagnosis and lymph node metastasis. Of all the processes involved in carcinogenesis, local invasion and distant metastasis are clinically the most relevant, but are the least well understood on a molecular level. Here, we find that in vivo, the α-catenin homologue-α-catulin, a protein originally reported to interact with Lbc Rho guanine nucleotide exchange factor, is highly expressed at the tumor invasion front and in the metastatic streams of cells in both malignant hHNSCCs and a mouse model of oral SCC. Knockdown of α-catulin in hHNSCC cell lines dramatically decrease the migratory and invasive potential of those cells in vitro and metastatic potential in xenotransplants in vivo. Analysis of tumors deficient in α-catulin showed that the tumor cells are unable to invade the surrounding stroma. Accordingly, transcriptional profiling of those tumors revealed that α-catulin ablation is accompanied by changes in genes involved in cell migration and invasion. Interestingly enough, in vitro experiments show that an upregulation of α-catulin expression correlates with the transition of tumor cells from an epithelial to a mesenchymal morphology, as well as an upregulation of epithelial-to-mesenchymal transition (EMT) markers vimentin and snail. Overall, these results strongly indicate that α-catulin contributes to the invasive behavior of metastatic cells and may be used as a prognostic marker and future therapeutic target for patients with cancer. Mol Cancer Res; 10(7); 892-903. ©2012 AACR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22648798      PMCID: PMC3482427          DOI: 10.1158/1541-7786.MCR-12-0169

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  38 in total

Review 1.  RHO-GTPases and cancer.

Authors:  Erik Sahai; Christopher J Marshall
Journal:  Nat Rev Cancer       Date:  2002-02       Impact factor: 60.716

2.  Actin cable dynamics and Rho/Rock orchestrate a polarized cytoskeletal architecture in the early steps of assembling a stratified epithelium.

Authors:  Alec Vaezi; Christoph Bauer; Valeri Vasioukhin; Elaine Fuchs
Journal:  Dev Cell       Date:  2002-09       Impact factor: 12.270

Review 3.  Alpha-catenin: at the junction of intercellular adhesion and actin dynamics.

Authors:  Agnieszka Kobielak; Elaine Fuchs
Journal:  Nat Rev Mol Cell Biol       Date:  2004-08       Impact factor: 94.444

Review 4.  Convergence of Wnt, beta-catenin, and cadherin pathways.

Authors:  W James Nelson; Roel Nusse
Journal:  Science       Date:  2004-03-05       Impact factor: 47.728

Review 5.  The physics of cancer: the role of physical interactions and mechanical forces in metastasis.

Authors:  Denis Wirtz; Konstantinos Konstantopoulos; Peter C Searson
Journal:  Nat Rev Cancer       Date:  2011-06-24       Impact factor: 60.716

6.  Clusters of chromosome 9 aberrations are associated with clinico-pathologic subsets of non-Hodgkin's lymphoma.

Authors:  K Offit; N Z Parsa; S C Jhanwar; D Filippa; M Wachtel; R S Chaganti
Journal:  Genes Chromosomes Cancer       Date:  1993-05       Impact factor: 5.006

Review 7.  MAP kinases and cell migration.

Authors:  Cai Huang; Ken Jacobson; Michael D Schaller
Journal:  J Cell Sci       Date:  2004-09-15       Impact factor: 5.285

8.  Metastatic squamous cell carcinoma cells that overexpress c-Met exhibit enhanced angiogenesis factor expression, scattering and metastasis in response to hepatocyte growth factor.

Authors:  Gang Dong; Tin Lap Lee; Ning T Yeh; Joel Geoghegan; Carter Van Waes; Zhong Chen
Journal:  Oncogene       Date:  2004-08-19       Impact factor: 9.867

9.  Diffuse large cell lymphomas exhibit frequent deletions in 9p21-22 and 9q31-34 regions.

Authors:  S R Chaganti; G Gaidano; D C Louie; R Dalla-Favera; R S Chaganti
Journal:  Genes Chromosomes Cancer       Date:  1995-01       Impact factor: 5.006

10.  Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2.

Authors:  D C Schultz; L Vanderveer; K H Buetow; M P Boente; R F Ozols; T C Hamilton; A K Godwin
Journal:  Cancer Res       Date:  1995-05-15       Impact factor: 12.701

View more
  15 in total

1.  Clinical significance of RacGAP1 expression at the invasive front of gastric cancer.

Authors:  Susumu Saigusa; Koji Tanaka; Yasuhiko Mohri; Masaki Ohi; Tadanobu Shimura; Takahito Kitajima; Satoru Kondo; Yoshinaga Okugawa; Yuji Toiyama; Yasuhiro Inoue; Masato Kusunoki
Journal:  Gastric Cancer       Date:  2014-03-11       Impact factor: 7.370

2.  CD44 staining of cancer stem-like cells is influenced by down-regulation of CD44 variant isoforms and up-regulation of the standard CD44 isoform in the population of cells that have undergone epithelial-to-mesenchymal transition.

Authors:  Adrian Biddle; Luke Gammon; Bilal Fazil; Ian C Mackenzie
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

3.  EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cells.

Authors:  Francesco La Rocca; Irma Airoldi; Emma Di Carlo; Pina Marotta; Geppino Falco; Vittorio Simeon; Ilaria Laurenzana; Stefania Trino; Luciana De Luca; Katia Todoerti; Oreste Villani; Martin Lackmann; Fiorella D'Auria; Francesco Frassoni; Antonino Neri; Luigi Del Vecchio; Pellegrino Musto; Daniela Cilloni; Antonella Caivano
Journal:  Cell Oncol (Dordr)       Date:  2017-07-18       Impact factor: 6.730

4.  RNA-seq reveals determinants for irinotecan sensitivity/resistance in colorectal cancer cell lines.

Authors:  Xin-Xiang Li; Hong-Tu Zheng; Jun-Jie Peng; Li-Yong Huang; De-Bing Shi; Lei Liang; San-Jun Cai
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

Review 5.  The Different Routes to Metastasis via Hypoxia-Regulated Programs.

Authors:  Ana Rita Nobre; David Entenberg; Yarong Wang; John Condeelis; Julio A Aguirre-Ghiso
Journal:  Trends Cell Biol       Date:  2018-07-23       Impact factor: 20.808

6.  Relapse pathway of glioblastoma revealed by single-cell molecular analysis.

Authors:  Xuelian Chen; Qin Wen; Andres Stucky; Yunjing Zeng; Shengjia Gao; William G Loudon; Hector W Ho; Mustafa H Kabeer; Shengwen Calvin Li; Xi Zhang; Jiang F Zhong
Journal:  Carcinogenesis       Date:  2018-07-03       Impact factor: 4.944

7.  Alpha-catulin contributes to drug-resistance of melanoma by activating NF-κB and AP-1.

Authors:  Birgit Kreiseder; Yvonne M Holper-Schichl; Barbara Muellauer; Nico Jacobi; Alexander Pretsch; Johannes A Schmid; Rainer de Martin; Harald Hundsberger; Andreas Eger; Christoph Wiesner
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

8.  Exosome-dependent immune surveillance at the metastatic niche requires BAG6 and CBP/p300-dependent acetylation of p53.

Authors:  Maximiliane Schuldner; Bastian Dörsam; Olga Shatnyeva; Katrin S Reiners; Andriy Kubarenko; Hinrich P Hansen; Florian Finkernagel; Katrin Roth; Sebastian Theurich; Andrea Nist; Thorsten Stiewe; Annette Paschen; Gero Knittel; Hans C Reinhardt; Rolf Müller; Michael Hallek; Elke Pogge von Strandmann
Journal:  Theranostics       Date:  2019-08-14       Impact factor: 11.556

9.  Microfluidic cytometric analysis of cancer cell transportability and invasiveness.

Authors:  Zongbin Liu; Yeonju Lee; Joon hee Jang; Ying Li; Xin Han; Kenji Yokoi; Mauro Ferrari; Ledu Zhou; Lidong Qin
Journal:  Sci Rep       Date:  2015-09-25       Impact factor: 4.379

10.  Loss of E-cadherin expression is not a prerequisite for c-erbB2-induced epithelial-mesenchymal transition.

Authors:  Gisela M A Nilsson; Noreen Akhtar; Marie Kannius-Janson; Dan Baeckström
Journal:  Int J Oncol       Date:  2014-05-07       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.